pills that have been registered in our database. Using GPS locator of the phone app, Pharmaceutical pills can be tracked/trace/authenticated in compliance with the 2013 US Drug Security Act! Able to to identify billions of individual drug tablets using an android smartphone app now available on Amazon Apps

https://goo.gl/m4WAhC

Big Data Analytics for Big Pharma

TruMedicines has patented a technology which allows a smartphone app to identify random patterns on drug pills. When a user scans a drug package barcode or pill, our 2 step, cloud based image recognition webservice performs image recognition matching to our image database on that drug tablet and provides text and audible information to the user- What, when, where, expiration date, adverse reaction rate, adverse multi-drug reaction rate, customized messages from Drug Distributor. All data is in compliance with the 2013 Drug Security Act. (requires full track/trace compliance for all drugs sold in USA by 2017).

The Problems

1) Counterfeit Drugs - National Association of Boards of Pharmacy (NABP) found in 2010 that 97 percent of the more than 10,900 Internet pharmacies were selling counterfeit drugs. The World Health Organization reports counterfeit drugs cause 1Mil deaths/year in developing countries, India, Africa, and Asia. In the United States a rising occurrence of 100,000 deaths/year are caused by adverse drug reactions, drug mistakes and overdoses. Peter Pitts, president of The Center for Medicine in the Public Interest and former FDA associate commissioner, estimates that in 2010, activities related to counterfeit drugs generated $75 billion, based on information obtained from government organizations. He expects it to grow by 20 percent annually in the coming years. If this estimate is correct, the counterfeit drug industry generates nearly as much cash as the world's fourth-largest wholesale drug company by revenue, AmerisourceBergen, which generated $79 billion in 2012.

2) Non-compliance to drug therapy (USA) - The annual costs of chronic conditions, such as diabetes and cardiovascular disease, are estimated to be $174 billion and $403 billion, respectively, in the United States. As these chronic disease costs continue to rise, managed care stakeholders and health insurance companies are continually looking for areas in which the quality of care can be improved and expenditures reduced. One such area is medication compliance, where increased compliance rates have demonstrated improved clinical outcomes and reduced overall medical expenditures.Source JMPC Jul 2008 vol 8

• up to 90% of diabetes patients do not take their medication well enough to benefit from that medication.

• 33-50% of some cancer patients take less of their anti-cancer medicine than required.

• only 75% of coronary heart disease (CHD) patients take sufficient medicine for it to be effective.

• Up to 75% of hypertensive patients do not adhere to their medicine.

• 41-59% of mentally ill patients take their medication infrequently or not at all.

• 33% of patients with schizophrenia don’t take their medicine at all, and 33% are poorly adherent.

• Less than 27% depressed patients adhere to their medication.

The Solution

TruMedicines has transformed drug tablets into data source points, which can be used for individual health improvement and collectively as a public health data source. TruMedicines is a “game changer” for how medicine is administered and how customers interact with medicine. See video https://youtu.be/FIrWhOtaU40

The Opportunity - Launch Phone App in USA

The pharmaceutical Industry is a $1.3Trillion/yr dollar global industry, USA is $350Billion dollar/yr. TruMedicines USA Adoption Rate – Scanning of drug tablets in USA will allow Healthcare provides the ability to monitor patient drug therapy compliance by patinets Self-monitoring using their cell phones.

Business Model

TruMedicines business model will provide 3 revenue streams:

A) Subscriptions for Big Data analytics – Healtchcare providers, Big Pharma, Regulatory

B) Advertising in Mobile app – Consumer Mobile app

C) licensing of Image recognition API as a SAAS

The Team

David Prokop – Founder/CEO

- Program Manager XBOX Kinect Optical Vision System Microsoft

- 16 years at Microsoft Program Manager in research and product groups

- 22 patents with successful license agreements with 11 fortune 500’s

- Inventor Marked Tablet US Patent # 8,888,005 Pats Pending

- Worked in Clinical studies/regulatory affairs

- Worked in Hospital in Middle east/ Africa

The Ask

Seed Capital of USD $500,000 – for software roll out and 1st customer acquisition.